Jerry S. Lanchbury is CSO at MYRIAD GENETICS INC (MYGN). They have made 17 open-market trades across 1 company since 2006, most recently 2021-10-09.
CIK 0001219036
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYGN | 264,324 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2021-10-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | SELL · 10b5-1 | 2021-09-23 | 2021-09-27 | $35.06 | $7K | -1.4% | -4.6% | -14.9% |
| MYGN | SELL | 2021-08-23 | 2021-08-25 | $35.32 | $2.8M | +2.0% | -3.8% | -19.9% |
| MYGN | SELL | 2021-08-05 | 2021-08-06 | $35.57 | $2.0M | -4.0% | +3.1% | -11.1% |
| MYGN | SELL | 2021-08-03 | 2021-08-05 | $34.68 | $4.5M | -6.5% | -1.6% | -18.4% |
| MYGN | SELL | 2021-07-12 | 2021-07-14 | $33.61 | $4.9M | +0.5% | +4.1% | +0.4% |
| MYGN | SELL | 2021-07-09 | 2021-07-12 | $32.62 | $3.3M | -5.2% | -4.3% | -8.0% |
| MYGN | SELL | 2021-07-07 | 2021-07-08 | $32.27 | $2.1M | -1.5% | +5.0% | -3.4% |
| MYGN | SELL | 2021-06-28 | 2021-06-30 | $32.37 | $410K | +6.6% | +2.3% | +2.4% |
| MYGN | SELL | 2021-06-25 | 2021-06-28 | $31.95 | $5.3M | +6.3% | +0.9% | +4.4% |
| MYGN | SELL | 2021-05-04 | 2021-05-05 | $31.97 | $1.2M | -2.4% | -0.7% | +27.2% |
| MYGN | SELL | 2021-04-27 | 2021-04-28 | $31.47 | $1.3M | -17.6% | -9.6% | -2.6% |
| MYGN | SELL | 2021-02-16 | 2021-02-17 | $29.71 | $4.8M | +4.5% | +3.2% | -7.4% |
| MYGN | SELL | 2018-07-11 | 2018-07-13 | $43.34 | $4.3M | +2.6% | -1.2% | +2.9% |
| MYGN | SELL | 2018-06-18 | 2018-06-19 | $40.12 | $4.8M | -6.2% | +9.8% | +16.3% |
| MYGN | SELL · 10b5-1 | 2015-10-28 | 2015-10-28 | $41.86 | $2.1M | -0.5% | +0.9% | -6.4% |
| MYGN | SELL · 10b5-1 | 2015-10-23 | 2015-10-27 | $41.80 | $1.0M | -0.5% | +0.9% | -7.1% |
| MYGN | SELL · 10b5-1 | 2015-09-15 | 2015-09-17 | $39.89 | $2.4M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2014-07-14 | 2014-07-15 | $39.85 | $797K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2014-04-02 | 2014-04-04 | $39.70 | $3.7M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2014-02-18 | 2014-02-20 | $34.55 | $1.2M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-12-03 | 2012-12-04 | $27.18 | $544K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2012-11-19 | 2012-11-21 | $30.59 | $887K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-11-06 | 2012-11-08 | $30.42 | $909K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-10-04 | 2012-10-09 | $28.50 | $111K | -0.5% | +0.9% | +0.9% |
| MYGN | SELL · 10b5-1 | 2012-10-03 | 2012-10-04 | $28.50 | $86K | -0.5% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.